The ink on a government contract does not dry overnight. It cures slowly, hidden deep inside quiet rooms where the air is climate-controlled and the conversations happen in a dialect of acronyms and plausible deniability. To the person standing in line at a local clinic, waiting hours just to find out if a nagging pain is something worse, the inner machinery of the state is completely invisible. They assume that the people running the system are looking out for them. They assume there is a firewall between public need and private profit.
They are wrong.
The wall is not made of brick. It is made of paper, and lately, it has begun to tear. When Samantha Jones, the permanent secretary at the Department for Health and Social Care, issued a formal apology for violating Westminster’s lobbying rules, the news was treated by the headlines as a dry, procedural hiccup. An administrative oversight. A minor breach of protocol regarding her ties to an advisory firm connected to Palantir, the American data-mining behemoth.
But reduce this to a bureaucratic clerical error and you miss the entire point. This is not a story about unfiled paperwork. It is a story about how modern power actually operates, how easily the public interest can be sublimated by corporate gravitational pull, and how the very people trusted to guard the gates often forget which side of the threshold they are supposed to be standing on.
The Quiet Architecture of Influence
To understand how a top civil servant ends up compromised, you have to look at the landscape they inhabit. Whitehall does not usually suffer from cartoonish, briefcases-of-cash corruption. The reality is far more subtle, far more polite, and infinitely more dangerous. It is built on relationships, overlapping roles, and the smooth, frictionless movement of elite personnel.
Consider the timeline. In November 2023, the NHS handed down a massive, highly controversial £330 million contract to build its new Federated Data Platform. The winner was Palantir, a company founded by Silicon Valley billionaire Peter Thiel, known deeply for its roots in military intelligence and immigration enforcement. It was an appointment that sent shivers through data privacy advocates.
While this monumental deal was being hammered out, Samantha Jones was sitting at the apex of the Department for Health as its lead non-executive director. At the exact same time, she was working as an adviser to Carnall Farrar, a boutique healthcare consultancy.
Here is the knot: Carnall Farrar was not just any consultancy. It was part of the bidding consortium aligned with Palantir to secure that very same NHS data goldmine.
Our regulatory system pretends these two identities can live inside the same skin without talking to each other. We are asked to believe in a kind of corporate psychological partitioning, where an individual can champion the public purse by day and counsel the profit margins of private contenders by night. Carnall Farrar later noted that Jones did not directly work on the Palantir contract.
But the influence of a high-ranking official does not require a specific pen stroke on a specific memo. Influence is an aura. It is the casual mention of a priority during a coffee break, the subtle framing of a problem that happens to match a specific corporate solution, or simply the weight of an opinion shared by someone who holds the keys to the kingdom.
The Watchdog with No Teeth
We have a mechanism designed specifically to prevent this. It is called the Advisory Committee on Business Appointments, or ACOBA. Its mandate sounds imposing. It is supposed to act as the traffic cop at the intersection of government service and corporate employment, policing the "revolving door" to ensure that former ministers and civil servants do not leverage their insider knowledge for private gain.
When Jones left her role as a health adviser in Downing Street under Boris Johnson, ACOBA granted her permission to do general consultancy work. But the permission came with an explicit, unshakeable condition: she had to seek advice from the committee for every single individual commission she wished to accept.
She did not do that.
She worked for Carnall Farrar before the clearance process was finished. When Baroness Gisela Stuart, the first civil service commissioner, launched an inquiry following investigative reporting, the cracks widened. Jones volunteered that she had taken on work for three other private healthcare tech companies—Human, System C, and Newmarket—without bothering to ask ACOBA first. She was also acting as an operating partner for G-Square Capital, a private equity firm with major stakes in public contracts, including children's homes.
The defense offered was entirely predictable. Administrative oversights. Good faith. A promise of careful reflection.
It is the language of an elite that views transparency as an irritating box-ticking exercise rather than a moral imperative. If the average citizen forgets to declare an income source on their taxes, the state does not accept "administrative oversight" as a shield against penalties. Yet, at the highest levels of governance, breaking the rules meant to protect the nation's health data from conflicts of interest is met with a gentle reprimand and an accepted apology.
The systemic failure here is structural. ACOBA is fundamentally a watchdog that cannot bite. It has no statutory power to fine, no mechanism to punish, and relies almost entirely on the public shaming of people who are frequently beyond the reach of shame. It operates on an honor system in an environment where honor has been commodified.
The Invisible Stakes
Why does this matter to the person waiting for their clinic appointment? Because data is the most valuable commodity on earth, and health data is the most intimate data we possess.
The NHS Federated Data Platform is designed to pull together the disparate, messy streams of patient information from across the country into a single, cohesive system. In theory, it is a magnificent idea. Properly managed, integrated data can predict outbreaks, streamline hospital bed allocations, and save lives.
But when the architecture of that platform is handed over to a foreign tech giant with deep ties to surveillance capitalism, the stakes become existential. The code running the software that manages your medical history belongs to a corporation whose explicit goal is to imbed itself so deeply into the fabric of state infrastructure that it becomes impossible to remove.
When civil servants blink, when they treat the rules governing their relationships with these companies as mere suggestions, they erode the one thing keeping the whole system afloat: trust.
If the public loses faith in how their medical data is handled, they stop sharing it. They opt out. Doctors lose the clear picture they need to treat illnesses, research stalls, and the NHS becomes weaker. The irony is bitter. In the pursuit of corporate efficiency and cutting-edge data solutions, the systemic negligence of leadership risks destroying the foundational asset of public medicine.
The Illusion of Separation
We like to think of our public institutions as monolithic, permanent structures, like the stone buildings lining Whitehall. We imagine they are insulated from the chaotic whims of the market.
They are not. They are porous. They are staffed by people who look at their peers in the private sector, see the salaries, see the prestige, and realize that the line between serving the public and serving the board of directors is thin enough to step over without breaking a sweat.
The danger of the Samantha Jones affair is not that she acted with malice. The danger is that she almost certainly believed she was doing nothing wrong. In the modern executive class, the blending of corporate interests and state function has become so normalized that the boundary lines have blurred into irrelevance. They breathe the same air, attend the same dinners, and speak the same bloodless language of synergy and delivery.
But a public health service cannot be run like a private equity portfolio. Its value cannot be measured purely in data efficiencies or contract valuations. Its ultimate metric is custody—the safe, ethical keeping of a nation's vulnerabilities.
The investigation has concluded. The letters have been exchanged. The department has reiterated its commitment to the highest standards of integrity, a phrase that has been repeated so often in Westminster it has lost all original meaning. The machinery keeps turning, the £330 million contract remains in place, and the revolving door spins on, silent and well-oiled.
Somewhere in a hospital corridor, a light flickers on a server rack. A patient’s file moves from a local drive into a massive, centralized cloud, managed by a company whose advisers used to run the department that signed the check. We are told everything is secure. We are told to trust the system. But it is getting harder to hear those assurances over the sound of the gates swinging wide open.
